1. Previous investigations have demonstrated an impaired endothelium-d
ependent vasodilatation (EDV) in patients with hypertension. The prese
nt study aimed to investigate if an acute rise in blood pressure to hy
pertensive levels impairs EDV in otherwise normotensive subjects. 2. T
wenty-seven young, healthy, normotensive subjects were studied. Eight
of these underwent evaluation of EDV and endothelium-independent vasod
ilatation (EIDV) by means of forearm blood flow measurements during lo
cal intra-arterial infusions of methacholine (2 and 4 mu g/min) and so
dium nitroprusside (5 and 10 mu g/min), before and after 1 h of sustai
ned hypertension, induced by noradrenaline given intravenously. Identi
cal measurements were made in 11 subjects before and during concomitan
t local intra-arterial infusion of noradrenaline without change in blo
od pressure and eight subjects were studied during saline infusions. 3
. One hour of sustained hypertension (diastolic blood pressure >95 mmH
g) significantly attenuated both forearm blood flow (17.4 +/- 6.8 vers
us 27.4 +/- 6.8 ml . min(-1) . 100 ml(-1) tissue at baseline, P < 0.05
) and forearm vascular resistance decrease (3.2 +/- 0.87 versus 7.4 +/
- 2.5 units at baseline, P < 0.05) during methacholine infusion. These
attenuations were significantly more pronounced for methacholine than
for sodium nitroprusside (P < 0,05), In contrast, local intra-arteria
l noradrenaline infusions impaired vasodilatation induced by methachol
ine and sodium nitroprusside to a similar extent. Saline infusions did
not change either EDV or EIDV, 4.Thus, an acute rise in blood pressur
e to hypertensive levels induced by noradrenaline impaired EDV more th
an EIDV in otherwise normotensive subjects, while no such selective ef
fect of local noradrenaline was seen, suggesting that a high blood pre
ssure impairs endothelial vasodilator function.